Fibronectin mediates APOE4-driven blood–brain barrier dysfunction in Alzheimer’s disease
It is shown that astrocyte-derived fibronectin (FN1) is a key mediator of apolipoprotein E4 (APOE4)-driven BBB dysfunction in AD, linking APOE ε4 and amyloid pathology to vascular damage and highlighting FN1 as a potential therapeutic target.